Zurich Cantonal Bank
ITOS

Zurich Cantonal Bank’s iTeos Therapeutics ITOS Stock Holding History

Zurich Cantonal Bank’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,574
Closed -$19.8K – 2657
2024
Q4 		$19.8K Sell
2,574
-9,354
-78% -$80.4K ﹤0.01% 2592
2024
Q3 		$122K Sell
11,928
-70
-0.6% -$1.07K ﹤0.01% 2355
2024
Q2 		$178K Buy
11,998
+3,172
+36% +$45.4K ﹤0.01% 2098
2024
Q1 		$120K Hold
8,826
– – ﹤0.01% 2307
2023
Q4 		$96.6K Buy
8,826
+3,069
+53% +$30.4K ﹤0.01% 2461
2023
Q3 		$63K Sell
5,757
-1
-0% -$13 ﹤0.01% 2534
2023
Q2 		$76.2K Buy
5,758
+4,239
+279% +$60.4K ﹤0.01% 2465
2023
Q1 		$20.7K Sell
1,519
-463
-23% -$8.29K ﹤0.01% 2749
2022
Q4 		$38.7K Sell
1,982
-141
-7% -$2.75K ﹤0.01% 2664
2022
Q3 		$40K Hold
2,123
– – ﹤0.01% 2659
2022
Q2 		$44K Hold
2,123
– – ﹤0.01% 2638
2022
Q1 		$68K Sell
2,123
-3,955
-65% -$144K ﹤0.01% 2438
2021
Q4 		$283K Buy
6,078
+4,322
+246% +$144K ﹤0.01% 1846
2021
Q3 		$47K Sell
1,756
-1
-0.1% -$26 ﹤0.01% 2631
2021
Q2 		$45K Buy
1,757
+116
+7% +$2.76K ﹤0.01% 2479
2021
Q1 		$56K Buy
+1,641
New +$59.3K ﹤0.01% 2362

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zurich Cantonal Bank's ITOS Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of iTeos Therapeutics (ITOS) in Q1 2025, closing a stake of 2,574 shares — an estimated $19.8K sold.

Zurich Cantonal Bank first reported a position in ITOS in Q1 2021 and held it in 16 quarters. The position peaked at $283K in Q4 2021. 131 funds tracked by Wall St. Rank hold ITOS as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining iTeos Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 2,574 iTeos Therapeutics shares in Q1 2025, an estimated $19.8K.
  • Zurich Cantonal Bank first reported a position in iTeos Therapeutics in Q1 2021 and held it in 16 quarters.
  • Zurich Cantonal Bank's iTeos Therapeutics position peaked at $283K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.